The University of Southampton
University of Southampton Institutional Repository

Epithelial-biofilm interaction in primary ciliary dyskinesia

Epithelial-biofilm interaction in primary ciliary dyskinesia
Epithelial-biofilm interaction in primary ciliary dyskinesia
Primary ciliary dyskinesia (PCD) is an inherited disorder of motile cilia that affects around 1 in 15,000 live births and its defining feature is a lack of mucociliary clearance. This results in progressive lung disease, upper airway symptoms and, potentially, situs inversus and infertility. PCD is characterised by early colonisation of the lower airways with bacteria, resulting in progressive lung function decline. Non-typeable Haemophilus influenzae (NTHi) is the commonest of these colonising bacteria in children and is also cultured in many other lung conditions such as cystic fibrosis, chronic obstructive pulmonary disease and bronchiectasis. NTHi forms biofilms on airway epithelium; a phenotype associated with increased tolerance to antibiotic treatment and resistance to host immunity. This work hypothesised that, in addition to lack of mucociliary clearance, the PCD airway has intrinsically dysregulated responses to colonising bacteria. This may be, in part, due to extremely low airway nitric oxide (NO). Thus, exogenous NO may represent a potential therapeutic adjunct in the treatment of lower airway infection. Systematic review and metaanalysis were used to define NO levels in PCD airway and healthy/disease controls. Then an established model of a 72h NTHi biofilm in vitro and on cultured primary respiratory epithelium was employed. NO treatment of these biofilms was investigated using a targeted NO compound (PYRRO-C3D) with the NO-treated NTHi in vitro biofilms subjected to label-free proteomic analyses to identify mechanisms underlying these treatment effects. Label-free proteomic analysis was also employed to identify differences in healthy and PCD epithelial proteome following exposure to 72h NTHi biofilm, as well as identifying NTHi proteins present. Systematic review and meta-analysis showed that PCD patients had extremely low nasal NO (mean 19.4nl/min) compared to healthy (265nl/min) and CF patients (123.2nl/min). This was independent of genotype or ultrastructural defect, thus there was a common epithelial defect across almost all PCD patients. PYRRO-C3D was effective in enhancing antibiotic treatment of NTHi biofilms in vitro and on cultured respiratory epithelium (p<0.05). This effect was more pronounced on PCD epithelium (2 log fold CFU drop) than healthy (1 log fold). Inhibition of NO release and scavenging of NO showed the effect to be NO mediated. Proteomic analysis revealed NO-induced upregulation of metabolic pathways and translational machinery, as well as a D-methionine uptake lipoprotein and iron metabolism. However, methionine isomers reversed the antibiotic enhancing effect of PYRRO-C3D. Pathway analysis of proteomic data from the co-culture model demonstrated that healthy epithelium responds to NTHi colonisation by cytoskeletal remodelling, metabolic upregulation and initial hyper-proliferation as well as suppression of acute inflammation via downregulation of S100 proteins. PCD epithelium appears to show a lesser degree of hyper-proliferation and fails to downregulate pro-inflammatory S100 proteins to the same extent. NTHi proteins were also identified in the analysis, with 14 present in both the co-culture samples and in vitro work, suggesting they warrant further investigation. OMPp5 (a HSP70 protein) is of particular interest as a potential biomarker or vaccine target. In conclusion, almost all PCD patients have extremely low airway NO regardless of underlying genotype, suggesting a common epithelial dysfunction. PCD epithelium may not respond adequately to NTHi colonisation as there is a failure of both normal proliferation and inflammatory suppression through downregulation of S100 proteins. Changes in intracellular calcium flux is a potential common mechanism behind failure of ciliary beat, low nitric oxide and S100/innate immune dysfunction. NO can also be successfully used as a targeted therapeutic adjunct in NTHi biofilms and may be particularly effective in PCD due to the constitutively low NO during colonisation. NO induces metabolic and translational changes in NTHi that make it more sensitive to treatment with macrolides and, potentially, other translation-targeting antibiotics. Proteins such as OMPp5 are common to in vitro and ex vivo biofilm models, suggesting the validity of in vitro models and showing promise as potential biomarkers of significant NTHi colonisation or targets of vaccines.
University of Southampton
Collins, Samuel
61e14369-4d16-4cdb-bf2c-8b27545d0fdb
Collins, Samuel
61e14369-4d16-4cdb-bf2c-8b27545d0fdb
Lucas, Jane
5cb3546c-87b2-4e59-af48-402076e25313

Collins, Samuel (2017) Epithelial-biofilm interaction in primary ciliary dyskinesia. University of Southampton, Doctoral Thesis, 287pp.

Record type: Thesis (Doctoral)

Abstract

Primary ciliary dyskinesia (PCD) is an inherited disorder of motile cilia that affects around 1 in 15,000 live births and its defining feature is a lack of mucociliary clearance. This results in progressive lung disease, upper airway symptoms and, potentially, situs inversus and infertility. PCD is characterised by early colonisation of the lower airways with bacteria, resulting in progressive lung function decline. Non-typeable Haemophilus influenzae (NTHi) is the commonest of these colonising bacteria in children and is also cultured in many other lung conditions such as cystic fibrosis, chronic obstructive pulmonary disease and bronchiectasis. NTHi forms biofilms on airway epithelium; a phenotype associated with increased tolerance to antibiotic treatment and resistance to host immunity. This work hypothesised that, in addition to lack of mucociliary clearance, the PCD airway has intrinsically dysregulated responses to colonising bacteria. This may be, in part, due to extremely low airway nitric oxide (NO). Thus, exogenous NO may represent a potential therapeutic adjunct in the treatment of lower airway infection. Systematic review and metaanalysis were used to define NO levels in PCD airway and healthy/disease controls. Then an established model of a 72h NTHi biofilm in vitro and on cultured primary respiratory epithelium was employed. NO treatment of these biofilms was investigated using a targeted NO compound (PYRRO-C3D) with the NO-treated NTHi in vitro biofilms subjected to label-free proteomic analyses to identify mechanisms underlying these treatment effects. Label-free proteomic analysis was also employed to identify differences in healthy and PCD epithelial proteome following exposure to 72h NTHi biofilm, as well as identifying NTHi proteins present. Systematic review and meta-analysis showed that PCD patients had extremely low nasal NO (mean 19.4nl/min) compared to healthy (265nl/min) and CF patients (123.2nl/min). This was independent of genotype or ultrastructural defect, thus there was a common epithelial defect across almost all PCD patients. PYRRO-C3D was effective in enhancing antibiotic treatment of NTHi biofilms in vitro and on cultured respiratory epithelium (p<0.05). This effect was more pronounced on PCD epithelium (2 log fold CFU drop) than healthy (1 log fold). Inhibition of NO release and scavenging of NO showed the effect to be NO mediated. Proteomic analysis revealed NO-induced upregulation of metabolic pathways and translational machinery, as well as a D-methionine uptake lipoprotein and iron metabolism. However, methionine isomers reversed the antibiotic enhancing effect of PYRRO-C3D. Pathway analysis of proteomic data from the co-culture model demonstrated that healthy epithelium responds to NTHi colonisation by cytoskeletal remodelling, metabolic upregulation and initial hyper-proliferation as well as suppression of acute inflammation via downregulation of S100 proteins. PCD epithelium appears to show a lesser degree of hyper-proliferation and fails to downregulate pro-inflammatory S100 proteins to the same extent. NTHi proteins were also identified in the analysis, with 14 present in both the co-culture samples and in vitro work, suggesting they warrant further investigation. OMPp5 (a HSP70 protein) is of particular interest as a potential biomarker or vaccine target. In conclusion, almost all PCD patients have extremely low airway NO regardless of underlying genotype, suggesting a common epithelial dysfunction. PCD epithelium may not respond adequately to NTHi colonisation as there is a failure of both normal proliferation and inflammatory suppression through downregulation of S100 proteins. Changes in intracellular calcium flux is a potential common mechanism behind failure of ciliary beat, low nitric oxide and S100/innate immune dysfunction. NO can also be successfully used as a targeted therapeutic adjunct in NTHi biofilms and may be particularly effective in PCD due to the constitutively low NO during colonisation. NO induces metabolic and translational changes in NTHi that make it more sensitive to treatment with macrolides and, potentially, other translation-targeting antibiotics. Proteins such as OMPp5 are common to in vitro and ex vivo biofilm models, suggesting the validity of in vitro models and showing promise as potential biomarkers of significant NTHi colonisation or targets of vaccines.

Text
Samuel Collins 27015599 Thesis - final - Version of Record
Available under License University of Southampton Thesis Licence.
Download (6MB)
Text
Permission to deposit form
Restricted to Repository staff only

More information

Published date: 29 June 2017

Identifiers

Local EPrints ID: 467420
URI: http://eprints.soton.ac.uk/id/eprint/467420
PURE UUID: 399bd336-6830-4cc8-91f5-90902264c8f2
ORCID for Jane Lucas: ORCID iD orcid.org/0000-0001-8701-9975

Catalogue record

Date deposited: 08 Jul 2022 16:31
Last modified: 17 Mar 2024 07:20

Export record

Contributors

Author: Samuel Collins
Thesis advisor: Jane Lucas ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×